Following Apple's shoutout during its earnings call, Perplexity is offering more details on why it is building its Mac-first ...

As more patients with cancer have their tumors genomically profiled, and more therapies targeting genomic alterations enter clinical trials, the task of connecting patients to trials for which they ...

TORONTO--(BUSINESS WIRE)--Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a metaverse Company and leading ...